HIGH

Cardinal Health Chest Drainage Units Recalled Over Infant Hazards

Cardinal Health recalled 1,169,726 chest drainage units on December 26, 2025. The recall stems from an update to the instructions for use (IFU) clarifying that the devices are intended for adults only. Using these devices on infants may result in delayed treatment and prolonged hospitalization.

Quick Facts at a Glance

Recall Date
December 26, 2025
Hazard Level
HIGH
Brand
Cardinal Health 200
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL, INFANTS

Hazard Information

The firm is updating the IFU to clarify the intended patient population for the identified chest drainage units and accessories as adults, 18 years and older. When used on infants, the CDU may not demonstrate tidaling/bubbling, which may confound the clinician's assessment of device functionality and lead to inadequate/inappropriate treatment/therapy, delay to treatment/therapy, and prolonged hospitalization.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Cardinal Health 200, LLC or your healthcare provider for instructions. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recall affects several models, including Cardinal Health Sentinel Seal CDU and Thora-Seal devices, with product codes ranging from 8888571562 to 8884713900. These units were distributed globally, including the US, Brazil, Canada, and Mexico.

The Hazard

The IFU update clarifies that these chest drainage units are intended for adults aged 18 and older. When used on infants, the devices may not function properly, potentially leading to inadequate treatment.

Reported Incidents

The recall does not specify the number of reported incidents or injuries. However, the potential for delayed treatment could lead to serious health consequences.

What to Do

Stop using the affected chest drainage units immediately. Contact Cardinal Health 200, LLC or your healthcare provider for further instructions regarding the recall.

Contact Information

For more information, contact Cardinal Health at 1-800-xxxx-xxxx or visit their website at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-1203-2026.

Key Facts

  • Recall Date: December 26, 2025
  • Distribution: US and several Latin American countries
  • Quantity: 1,169,726 units
  • Classification: Class II

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALINFANTS
Injury Types
OTHER

Product Details

Model Numbers
All units affected by IFU update. UDI-DI: 1. 8888571562 Cardinal Health Sentinel Seal CDU 50192253003091 (CS) 10192253003093 (EA) 2. 8888571513 Cardinal Health Sentinel Seal CDU
Dual Drain 50192253003084 (CS) 10192253003086 (EA) 3. 8888571489 Cardinal Health Sentinel Seal CDU
with Easy Change Connector 50192253003077 (CS) 10192253003079 (EA) 4. 8888571370 Cardinal Health Altitude CDU
Dry Suction
with Easy Change Connector 50192253003039 (CS) 10192253003031 (EA) 5. 8888571299 Cardinal Health Aqua-Seal CDU
+12 more
Affected States
ALL
Report Date
February 4, 2026
Recall Status
ACTIVE

Related Recalls

HIGH

Fresenius Kabi Vancomycin Injection Recalled Over Sterility Concerns

Fresenius Kabi Compounding recalled its vancomycin HCl injection on February 5, 2026, due to a lack of assurance of sterility. This Class II recall affects all lots distributed nationwide. Healthcare providers and consumers must stop using the product immediately.

Fresenius Kabi Compounding
Lack of
Read more
HIGH

Fresenius Kabi Compounding Issues Recall of Vancomycin Injection

Fresenius Kabi Compounding recalled 1,578 bags of vancomycin HCl injection on February 5, 2026. The company cited a lack of assurance of sterility as the reason for the recall. Healthcare providers and consumers should stop using the product immediately.

Fresenius Kabi Compounding
Lack of
Read more
HIGH

Pro Numb Tattoo Numbing Spray Recalled Due to cGMP Violations

Pro Numb Tattoo Numbing Spray was recalled on February 2, 2026 due to cGMP deviations. The product, containing 4% lidocaine, is distributed by Pro Numb Tattoo Numbing Spray LLC. Consumers should stop using it immediately and contact the company for further guidance.

PRO NUMB SENSITIVE SKIN
cGMP deviations
Read more